Maud D.
- Country
- Belgium
- Department
- Pneumology
Research Overview
- Phase 3 Randomized, Double-Blind, Placebo-Controlled Study of Camlipixant in Adults with Refractory or Unexplained Chronic Cough
- Evaluation of Response Predictors to Omalizumab and Mepolizumab in Severe Allergic and Eosinophilic Asthma: A Multinational Randomized Controlled Trial
- Efficacy and Safety Evaluation of PF-07275315 in Adults with Moderate-to-Severe Asthma: A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study
Data & Insights
Has run more than one trial at 27 of 121 partner sites.
Specializations
Respiratory Conditions
This investigator specializes in treating complex respiratory disorders, with particular emphasis on refractory chronic cough and unexplained chronic cough. Their research encompasses innovative therapeutic approaches for managing persistent cough conditions that are resistant to conventional treatments.
- Chronic Cough Management
- Refractory Cough Therapeutics
- Long-term Cough Assessment
Severe Asthma Treatment
The investigator focuses on advanced treatments for severe allergic and eosinophilic asthma. Their work involves evaluating biological therapies and their effectiveness in managing severe asthma presentations, particularly examining treatment responses in different patient populations.
- Biological Therapy Assessment
- Asthma Exacerbation Management
- Allergic Asthma Control
Therapeutic Innovation
Expertise extends to investigating novel approaches in maintenance therapy reduction for severe asthma patients. The investigator's work includes evaluating long-term asthma control strategies and biomarker-guided treatment optimization.
- Treatment Optimization
- Biomarker Assessment
- Maintenance Therapy Management
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.